CervoMed Inc. (CRVO) › Cash & EquivalentsCervoMed Inc. (CRVO) — Cash & EquivalentsAnnual figures by fiscal year, from SEC filings.2011: $98.4K2012: $312.1K2013: $255.0K2014: $2.34M2015: $2.00M2016: $1.55M2017: $8.90M2018: $7.99M2019: $14.18M2020: $18.52M2021: $37.31M2022: $4.09M2023: $7.79M2024: $9.00M2025: $8.24M$8.24M2011Cash & Equivalents (USD)2025Fiscal YearCash & EquivalentsChange YoY2025$8.24M-8.5%2024$9.00M+15.5%2023$7.79M+90.4%2022$4.09M-89.0%2021$37.31M+101.5%2020$18.52M+30.6%2019$14.18M+77.4%2018$7.99M-10.2%2017$8.90M+472.9%2016$1.55M-22.2%2015$2.00M-14.5%2014$2.34M+816.4%2013$255.0K-18.3%2012$312.1K+217.0%2011$98.4K—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share